Takara Bio

Takara Bio is the first company in Japan to sell PCR technology and the developer of RetroNectin reagent, which is used as the world standard in gene therapy protocols. In addition to providing research reagents and equipment to the life science research market, Takara Bio is also actively engaged in research and product development in the fields of gene and cell-based therapies as well as agricultural biotechnology; it is committed to preventing diseases and improving the quality of life for everyone through the use of biotechnology. By forming strategic alliances with other industry leaders, Takara Bio aims to expand its business reach worldwide.